Lupin Q3 results: Net jumps 300% to Rs 613 cr on back of record sales
North America sales for Q3 FY 2024 were Rs 1,888.5 crore, up 23.7 per cent Y-o-Y. North America accounted for
Continue readingThe Number One Finance & Business Blog!
North America sales for Q3 FY 2024 were Rs 1,888.5 crore, up 23.7 per cent Y-o-Y. North America accounted for
Continue readingAhmedabad-based pharma company Torrent Pharmaceuticals posted a 51 per cent year-on-year (Y-o-Y) increase in consolidated Profit After Tax (PAT)
Continue readingDr Reddy’s Laboratories (DRL) said on Wednesday that it has entered into an exclusive collaboration with US-based Coya Therapeutics
Continue reading